Paliperidone extended-release: does it have a place in antipsychotic therapy?
Maximilian Gahr1,*, Markus A Kölle1,*, Carlos Schönfeldt-Lecuona1, Peter Lepping2, Roland W Freudenmann11Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany; 2Department of Psychiatry, Glyndwr University, Wales, UK *Both authors contributed equally a...
Main Authors: | Carlos Schönfeldt-Lecuona, Markus A Kölle, Maximilian Gahr, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/paliperidone-extended-release-does-it-have-a-place-in-antipsychotic-th-a6649 |
Similar Items
-
Antipsychotics and risk of venous thromboembolism: A population-based case-control study
by: Anna K Jönsson, et al.
Published: (2009-03-01) -
It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis
by: Umar N, et al.
Published: (2012-03-01) -
Psychometric properties of the Norwegian version of the General Health Questionnaire (GHQ-30) among older people living at home
by: Dale B, et al.
Published: (2012-11-01) -
Effect on work ability after team evaluation of functioning regarding pain, self-rated disability, and work ability assessment
by: Jan-Rickard Norrefalk, et al.
Published: (2010-08-01) -
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study
by: Papanicolaou Sotiria, et al.
Published: (2008-08-01)